HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
87.30
-0.81 (-0.92%)
At close: May 26, 2026, 4:00 PM EDT
87.25
-0.05 (-0.06%)
After-hours: May 26, 2026, 4:00 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, HealthEquity stock has a consensus rating of "Buy" and an average price target of $112.88. The average 1-year stock price forecast is 29.30% higher than the current stock price, while the lowest is $86 (-1.49%) and the highest is $128 (+46.62%).
Price Target: $112.88 (+29.30%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 9 | 9 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 16 | 16 | 16 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Reiterates $110 | Buy | Reiterates | $110 | +26.00% | May 22, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $125 | Buy | Maintains | $125 | +43.18% | May 18, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
| BMO Capital | BMO Capital | Buy Upgrades $85 → $105 | Buy | Upgrades | $85 → $105 | +20.27% | Apr 9, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $123 | Buy | Maintains | $123 | +40.89% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
1.43B
from 1.31B
Increased by 8.57%
Revenue Next Year
1.55B
from 1.43B
Increased by 8.42%
EPS This Year
4.67
from 2.46
Increased by 89.91%
EPS Next Year
5.39
from 4.67
Increased by 15.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 1.5B | 1.7B | |
| Avg | 1.4B | 1.5B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 13.1% | 16.3% | |
| Avg | 8.6% | 8.4% | |
| Low | 4.8% | 2.4% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 4.97 | 6.28 | |
| Avg | 4.67 | 5.39 | |
| Low | 4.46 | 5.00 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 101.9% | 34.5% | |
| Avg | 89.9% | 15.5% | |
| Low | 81.3% | 7.0% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.